A 42-year-old woman on thiazide diuretics for hypertension presents with symptomatic hyponatremia (Na 122 mEq/L). She is euvolemic on examination. Serum osmolality is 250 mOsm/kg and urine osmolality is 580 mOsm/kg. Which investigation would best differentiate thiazide-induced hyponatremia from SIADH?

## Differentiating Thiazide-Induced Hyponatremia from SIADH **Key Point:** Both thiazide-induced hyponatremia and SIADH present with euvolemic hypotonic hyponatremia and inappropriately elevated urine osmolality. The **best practical investigation to differentiate them is urine sodium concentration (spot) and 24-hour urine sodium**, which reflects the underlying natriuretic mechanism of thiazides versus the water-retention mechanism of SIADH. ### Pathophysiologic Distinction | Feature | Thiazide-Induced | SIADH | |---------|------------------|-------| | **Mechanism** | Impaired diluting ability + obligatory natriuresis | Autonomous ADH → water retention, dilutional hyponatremia | | **Urine sodium** | **Markedly elevated (often >80 mEq/L)** due to direct natriuretic effect of thiazide | Elevated (>40 mEq/L) but driven by euvolemic state, not drug natriuresis | | **24-hr urine sodium** | **Very high** (reflects ongoing drug-induced sodium wasting) | Moderate elevation | | **Plasma vasopressin** | May be secondarily elevated — not a reliable discriminator | Elevated | | **Serum osmolality** | Low | Low | | **Urine osmolality** | High | High | | **Response to drug withdrawal** | Corrects rapidly | Persists | ### Why Urine Sodium is the Best Differentiator Thiazides act on the distal convoluted tubule to inhibit NaCl reabsorption, causing **obligatory urinary sodium wasting** independent of volume status. This results in disproportionately high urine sodium (often >80 mEq/L) and high 24-hour urinary sodium excretion. In SIADH, urine sodium is elevated (>40 mEq/L) due to euvolemia-driven natriuresis, but the degree of sodium wasting is far less pronounced and 24-hour sodium excretion is lower. This quantitative difference makes urine sodium the most practical and discriminating test. **Why not plasma vasopressin (Option A)?** Contrary to classic teaching, plasma vasopressin is often **not suppressed** in thiazide-induced hyponatremia — secondary ADH release can occur due to subclinical volume depletion or nausea. Both conditions may show elevated ADH, making vasopressin measurement a **poor discriminator** in clinical practice. Furthermore, plasma vasopressin assays are not routinely available and are not standard NEET PG differentiating tools. **Why not TSH/free T4 (Option B)?** Hypothyroidism can cause hyponatremia but is not the competing diagnosis in this stem. TSH does not differentiate thiazide effect from SIADH. **Why not ACTH stimulation test (Option C)?** Adrenal insufficiency causes hyponatremia but is not the competing diagnosis here. The ACTH stimulation test is used to exclude cortisol deficiency, not to distinguish thiazide effect from SIADH. **High-Yield (Harrison's Principles of Internal Medicine, 21st ed.; Sterns RH, NEJM 2015):** In the clinical differentiation of thiazide-induced hyponatremia from SIADH, **urine sodium concentration and 24-hour urine sodium** are the most practical and discriminating investigations. Thiazide-induced cases show markedly elevated urinary sodium loss reflecting direct tubular drug action, whereas SIADH shows more modest natriuresis. **Clinical Pearl:** After stopping the thiazide, rapid correction of hyponatremia with normalization of urine sodium further confirms the diagnosis — a response not seen in SIADH. **Mnemonic: "Thiazide = Salt waster (high UNa); SIADH = Water retainer (moderate UNa)"**